Designed for preclinical research, Neumous’ focused ultrasound platform enables
precise and controlled BBB opening to support the delivery of therapeutics to
targeted regions of the brain.
R&D
Preclinical Device
A research-use-only focused ultrasound system designed to support translational
research in targeted drug delivery and neuromodulation.
The system provides a platform for evaluating new ultrasound-based treatment approaches and
supports collaboration with pharmaceutical and research partners throughout preclinical development.
BBB Opening
Temporarily and locally opens the blood-brain barrier using focused ultrasound.
Targeted Drug Delivery
Enhances the delivery of therapeutic agents to targeted brain regions by overcoming the BBB.